|
May 31
|
How To Invest: Using Shorter-Term Moving Averages To Trade Stocks
|
|
May 31
|
European Commission approves Biogen’s QALSODY for ALS treatment
|
|
May 30
|
Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS
|
|
May 29
|
Qiagen (QGEN) Up 1.6% Since Last Earnings Report: Can It Continue?
|
|
May 29
|
Interim results of IGNAZ trial sheds positive light on felzartamab for IgAN
|
|
May 28
|
Is Biogen Inc.'s (NASDAQ:BIIB) Recent Price Movement Underpinned By Its Weak Fundamentals?
|
|
May 27
|
South Korea’s MFDS approves Eisai-Biogen’s LEQEMBI for Alzheimer’s
|
|
May 27
|
The Biggest Biotechnology Company in Europe
|
|
May 26
|
The Biggest Publicly Traded Biotech Company
|
|
May 24
|
Why Is Biogen (BIIB) Up 7.7% Since Last Earnings Report?
|
|
Apr 1
|
Biogen Inc. (BIIB) Falls More Steeply Than Broader Market: What Investors Need to Know
|
|
Jan 13
|
BIIB, ZTS, EXAS: Which “Strong Buy” Healthcare Stock is Best?
|
|
Jan 11
|
Is Eli Lilly Stock A Buy As It Battles In Obesity Drugs With A New Direct-To-Consumer Website?
|
|
Jan 11
|
EU regulators to consult advisers in review of Eisai Alzheimer’s drug
|